DNA topoisomerases as molecular targets for anticancer drugs

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Topoisomerases are essential enzymes regulating DNA topology and are vital for cellular function.
• Their critical role makes them significant targets for scientific research and drug development.

Purpose of the Study:

• To provide a comprehensive review of topoisomerases and their inhibitors.
• To discuss structure-activity relationships and molecular docking in drug development.
• To highlight topoisomerase inhibitors in clinical trials for cancer chemotherapy.

Main Methods:

• Literature review of existing research on topoisomerases and their inhibitors.
• Analysis of structure-activity relationships (SAR) for various compound classes.
• Examination of molecular docking studies relevant to topoisomerase inhibition.

Main Results:

• Detailed information on molecular targets and the SAR of topoisomerase inhibitors.
• Insights into how compound structures influence the mode of action of inhibitors.
• Identification of selected inhibitors currently in clinical trials for cancer treatment.

Conclusions:

• Topoisomerases are key targets in drug discovery due to their essential cellular roles.
• Understanding SAR and molecular interactions is crucial for developing effective topoisomerase inhibitors.
• Several topoisomerase inhibitors show promise for future cancer chemotherapy applications.